Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Expertise in Blood and Bone Marrow Transplant (BMT)
The Stanford Blood and Marrow Transplant Program combines 25 years of treatment expertise, state-of-the-art research and comprehensive support services to provide the best possible outcomes. Offering treatment for malignant and non-malignant diseases, including lymphoma, myeloma, leukemia, myelodysplastic syndromes, and selected solid tumors, our program strives to integrate each patient into normal, everyday life.
Are you a patient or physician interested in CAR-T gene therapy? To make an appointment with one of our cancer specialists, call 650-498-6000.
There are several types of blood and bone marrow transplants depending on who serves as the donor. The source of the hematopoietic (blood forming) cells further defines the type of transplant. The hematopoietic cells used for transplantation can be collected from the blood or the bone marrow. Hematopoietic cells, sometimes referred to as blood stem cells, are immature cells capable of dividing and developing into any type of mature blood cells.
method of replacing blood-forming cells destroyed by cancer treatment
to help the bone marrow recover and continue to make healthy blood
Expanded treatment options
Traditional transplantation methods are being advanced at Stanford to help all of our patients. These modified approaches include autologous transplantation followed by a reduced intensity allogeneic transplant, the use of a haploidentical donor, graft selection techniques, cellular therapy, monoclonal antibodies and vaccinations, and new treatment approaches for many diseases, including our protocol for mycosis fungoides.
If you are considering a transplant, your Stanford Blood and Marrow Transplant Program doctor will discuss which options could be most beneficial to you.
To commemorate the 30-year anniversary of blood and marrow transplantation at Stanford, the BMT program held a celebration for its more than 300 faculty, nurses and staff on Nov. 2, 2017.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Maps, directions, parking, public transit options, and contact information
Other patient resources
The initial evaluation process begins with a referral from your hematologist or oncologist to a Stanford Blood and Marrow Transplantation Program doctor. After this referral, the Stanford Blood and Marrow Transplant Program new patient coordinator will call you with an appointment date and time.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.